Preventing type 1 diabetes in animal model has been achieved by scientists. Type 1 diabetes is a chronic autoimmune disease that results from the destruction of insulin producing pancreatic beta cells.
Type I diabetes is a chronic autoimmune disease that occurs when the body's immune system destroys insulin producing pancreatic beta cells, resulting in insulin deficiency and hyperglycemia and current treatments for type I diabetes focus on controlling blood sugar with insulin therapy and must continue throughout a person's life.
Eating Disorders in Type 1 Diabetes
Adolescents with type 1 diabetes are at increased risk for developing psychiatric disorders, including eating disorders, due to the chronic nature of the disease.
Advertisement
In the new study, researchers at Saint Louis University focused on blocking the autoimmune process that destroys beta cells and leads to diabetes, with the aim of developing therapies that can prevent the illness from developing rather than treating its symptoms.
Researcher Thomas Burris said that none of the animals on the treatment developed diabetes even when they started treatment after significant beta cell damage had already occurred and they believe this type of treatment would slow the progression of type I diabetes in people or potentially even eliminate the need for insulin therapy.
![Six Staggering Diabetes Facts]( "Six Staggering Diabetes Facts")
Scientists already knew that at least two types of immune "T-cells" contribute to the development of type I diabetes, but the role of a third type, TH17, remained unclear.
In this study, researchers found that two nuclear receptors play critical roles in the development of TH17 cells and that by targeting these receptors, they were able to stop autoimmunity from developing in several mouse models, sparing beta cells.
The team blocked the receptors (ROR alpha and gamma t) with SR1001 (a selective ROR alpha and gamma t-inverse agonist developed by Burris), significantly reducing diabetes in mice that were treated with it.
These results confirm that TH17 cells likely play a key role in the development of type I diabetes and suggest that the use of drugs that target this cell type may offer a new treatment for the illness.
The study is published in Endocrinology.
Source: ANI
Advertisement
Scientists already knew that at least two types of immune "T-cells" contribute to the development of type I diabetes, but the role of a third type, TH17, remained unclear.
In this study, researchers found that two nuclear receptors play critical roles in the development of TH17 cells and that by targeting these receptors, they were able to stop autoimmunity from developing in several mouse models, sparing beta cells.
The team blocked the receptors (ROR alpha and gamma t) with SR1001 (a selective ROR alpha and gamma t-inverse agonist developed by Burris), significantly reducing diabetes in mice that were treated with it.
These results confirm that TH17 cells likely play a key role in the development of type I diabetes and suggest that the use of drugs that target this cell type may offer a new treatment for the illness.
The study is published in Endocrinology.
Source: ANI
Importance of Internet for Pregnant Women With Type 1 Diabetes
The use of internet by pregnant women with type 1 diabetes is on the increase. Internet can provide quality information besides support from health professionals.
Advertisement
 Quiz on Diabetes MedicationsHow much do you know about the medications used to treat diabetes? Here are a few questions you could attempt to test your knowledge. | Advertisement
|
Advertisement
Recommended Reading
Latest Diabetes News
Type 2 diabetes mice injected with beta cells with increased CD63 protein marker production had their blood sugar levels restored to normal.
Good news to children with diabetes: New artificial pancreas can help improve blood sugar control in kids.
New study reveals the link between pre-sleep light exposure and gestational diabetes mellitus in pregnant women.
Spinal cord stimulation delivers electrical stimulation to the spinal cord to cut off pain signals to the brain and may ease pain associated with diabetic neuropathy.
Cognitive behavioral therapy delivered via smartphone app was found to lower blood sugar levels in type 2 diabetes people.